From the Journals

USPSTF reaffirms need for folic acid supplements in pregnancy

View on the News

Supplementation remains prudent

The USPSTF recommendation that all women of childbearing age take folic acid supplements is a prudent one. Ideally, it will educate all women who are planning or capable of pregnancy to follow this recommendation and thereby reduce the risk of these severe birth defects in their infants.

Should the USPSTF recommendation be rejected because fortified food is already providing sufficient folic acid to prevent neural tube defects? No. Too little is known about how folic acid prevents neural tube defects. For example, it is not known whether the tissue stores of folate in the developing embryo or the availability of folate in the serum during the all-important few days of neural tube closure is most important. Habitual use of folic acid supplements is a more reliable method of ensuring adequate levels than is diet. In theory, a woman might not consume sufficient enriched cereal grains during the critical period of approximately 1 week when the neural tube is closing. Exactly when folate must be available also is not known. In addition, some popular diets, such as low carbohydrate or gluten free, may reduce exposure to grains, limiting folic acid intake.

James L. Mills, MD, is in the Division of Intramural Population Health Research at the Eunice Kennedy Shriver National Institute of Child Health and Human Development in Bethesda, Md. He reported having no relevant financial disclosures. These comments are adapted from an editorial accompanying the USPSTF report (JAMA. 2017;317 [2]:144-5).


 

FROM JAMA

The U.S. Preventive Services Task Force continues to recommend that all women planning or capable of pregnancy should take a daily supplement of 0.4-0.8 mg of folic acid to prevent neural tube defects in their offspring.

The task force “concludes with high certainty” that the benefits of such supplementation are substantial and the harms are minimal, according to the recommendation statement published online Jan. 10 in JAMA (2017;317[2]:183-9). The group based its updated recommendation on a systematic review of 24 studies performed since 2009 and involving 58,860 women. Although some newer studies have suggested that supplementation is no longer needed in this era of folic acid fortification of foods, “the USPSTF found no new substantial evidence ... that would lead to a change in its recommendation from 2009,” the researchers wrote.

Folic acid supplement pills Thinkstock
Half of all pregnancies in the United States are unplanned, and the critical period for supplementation starts at least 1 month before conception and extends through the first 2-3 months of pregnancy. Current data show that despite food fortification, 75% of nonpregnant women of childbearing age still do not consume the daily intake of folic acid recommended to prevent neural tube defects. The average annual prevalence of anencephaly and spina bifida is 6.5 cases per 10,000 live births.

The most recent data estimate that folic acid supplementation prevents neural tube defects in approximately 1,300 births each year.

This updated USPSTF recommendation is in accord with recommendations from the Health and Medicine Division of the National Academies (formerly the Institute of Medicine), the American College of Obstetricians and Gynecologists, the American Academy of Family Physicians, the U.S. Public Health Service, the Centers for Disease Control and Prevention, the American Academy of Pediatrics, the American Academy of Neurology, and the American College of Medical Genetics and Genomics.

This work was supported solely by the USPSTF, an independent voluntary group mandated by Congress to assess preventive care services and funded by the Agency for Healthcare Research and Quality.

Recommended Reading

Acetaminophen use in pregnancy: What is the evidence?
MDedge ObGyn
Three good apps for calculating the date of delivery
MDedge ObGyn
Letters to the Editor: Patient with a breast mass: Why did she pursue litigation?
MDedge ObGyn
Letters to the Editor: Avoid uterine vessels when injecting vasopressin
MDedge ObGyn
2017 Update on obstetrics
MDedge ObGyn
FDA warns of false-positive results with Zika IgM test
MDedge ObGyn
Which maternal beta-blockers boost SGA risk?
MDedge ObGyn
Cardiovascular complications in pregnancy quickly boost future risk
MDedge ObGyn
First-trimester blood glucose predicts congenital heart disease risk
MDedge ObGyn
United States about to top 40,000 Zika cases
MDedge ObGyn